| Income Statement |
| Total Revenue | 91.87M |
|
| Revenues (USD) | 91.87M |
| Cost of Revenue | 10.76M |
| Gross Profit | 81.11M |
| Operating Expenses | 64.32M |
| Research and Development Expense | 34.01M |
| Selling, General and Administrative Expense | 26.40M |
| Operating Income | 16.79M |
| Interest Expense | 255.00K |
| Income Tax Expense | 2.64M |
| Net Income | 17.75M |
| Net Income Common Stock | 17.75M |
| Net Income Common Stock (USD) | 17.75M |
| Consolidated Income | 17.75M |
| Earnings per Basic Share | 0.12 |
| Earnings per Basic Share (USD) | 0.12 |
| Earnings per Diluted Share | 0.10 |
| Earning Before Interest & Taxes (EBIT) | 20.65M |
| Earning Before Interest & Taxes (USD) | 20.65M |
| Weighted Average Shares | 150.09M |
| Weighted Average Shares Diluted | 174.05M |
| Balance Sheet |
| Cash and Equivalents | 465.51M |
| Cash and Equivalents (USD) | 465.51M |
| Investments | 816.88M |
| Investments Current | 816.88M |
| Trade and Non-Trade Receivables | 333.49M |
| Current Assets | 1.65B |
| Property, Plant & Equipment Net | 13.42M |
| Total Assets | 1.78B |
| Debt Current | 9.45M |
| Total Debt | 13.60M |
| Current Liabilities | 1.16B |
| Debt Non-Current | 4.15M |
| Total Liabilities | 1.16B |
| Accumulated Retained Earnings (Deficit) | -111.42M |
| Shareholders Equity | 619.86M |
| Shareholders Equity (USD) | 619.86M |
| Assets Non-Current | 130.89M |
| Total Debt (USD) | 13.60M |
| Liabilities Non-Current | 5.92M |
| Trade and Non-Trade Payables | 320.18M |
| Tax Assets | 113.92M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.99M |
| Net Cash Flow from Financing | -23.57M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 23.47M |
| Capital Expenditure | -268.00K |
| Issuance (Purchase) of Equity Shares | -22.81M |
| Issuance (Repayment) of Debt Securities | 4.93M |
| Net Cash Flow from Investing | -268.00K |
| Net Cash Flow from Operations | 47.31M |
| Share Based Compensation | 16.43M |